Information  X 
Enter a valid email address

AllergyTherapeutics Ord 0.1P (AGY)

Date Time Source Announcement
23 May 2022 7:00 am
RNS
Allergy Therapeutics at H.C. Wainwright Conference
25 Apr 2022 7:00 am
RNS
Allergy Therapeutics shares data at WAO-BSACI
08 Mar 2022 7:00 am
RNS
Allergy Therapeutics at Cowen Health Conference
07 Mar 2022 7:00 am
RNS
Allergy Therapeutics at Investor Meet Company
03 Mar 2022 7:00 am
RNS
Allergy Therapeutics plc - Interim Results
01 Mar 2022 7:00 am
RNS
Allergy Therapeutics shares positive new data
24 Feb 2022 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
  2:06 pm
RNS
Second Price Monitoring Extn
  2:01 pm
RNS
Price Monitoring Extension
02 Feb 2022 11:05 am
RNS
Secures new revolving credit facility
01 Feb 2022 2:16 pm
RNS
Total Voting Rights
26 Jan 2022 7:00 am
RNS
FDA clearance of IND application for VLP Peanut
24 Jan 2022 1:13 pm
RNS
Holding(s) in Company
13 Jan 2022 7:00 am
RNS
Half Year Trading Update & Notice of Results
05 Jan 2022 8:47 am
RNS
Total Voting Rights
25 Nov 2021 9:17 am
RNS
Allergy Therapeutics: Granting of Awards
23 Nov 2021 12:54 pm
RNS
Result of AGM
11 Nov 2021 7:00 am
RNS
Director Dealings
27 Oct 2021 7:00 am
RNS
Cheryl MacDiarmid appointed to Board of Directors
25 Oct 2021 9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Allergy announces positive G309 results
14 Oct 2021 9:24 am
RNS
Holding(s) in Company
07 Oct 2021 4:37 pm
RNS
Annual Report and AGM Notification
23 Sep 2021 7:00 am
RNS
Preliminary Results for Year ended 30 June 2021
16 Sep 2021 7:00 am
RNS
ImmunoBON voted Most Innovative Product of 2021
13 Sep 2021 7:00 am
RNS
Secondary endpoints from VLP Peanut 001
09 Sep 2021 7:00 am
RNS
Allergy to Present at H.C. Wainwright Conference
07 Sep 2021 7:00 am
RNS
Allergy to host KOL webinar on VLP Peanut
03 Aug 2021 7:00 am
RNS
Successful primary outcome of VLP Peanut 001
02 Aug 2021 10:57 am
RNS
Total Voting Rights
14 Jul 2021 7:00 am
RNS
Trading update for the year ended 30 June 2021
08 Jul 2021 7:00 am
RNS
AGY to present key scientific findings at EAACI
24 Jun 2021 7:00 am
RNS
Trading Update
01 Jun 2021 3:36 pm
RNS
Total Voting Rights
10 May 2021 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
06 May 2021 7:00 am
RNS
Completion of treatment phase in G309 study
30 Apr 2021 5:47 pm
RNS
Total Voting Rights
16 Apr 2021 7:00 am
RNS
Appointment of new Group auditors
31 Mar 2021 8:29 am
RNS
Vesting of Awards under Long Term Incentive Plan
26 Mar 2021 4:39 pm
RNS
Pledge of Shares
11 Mar 2021 12:13 pm
RNS
Pledge of Shares
10 Mar 2021 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
08 Mar 2021 7:00 am
RNS
AGY to Present at H.C. Wainwright Conference
03 Mar 2021 7:00 am
RNS
Interim Results for six months ended 31 Dec 2020
15 Jan 2021 7:00 am
RNS
Block Listing Return and Total Voting Rights
13 Jan 2021 7:00 am
RNS
Half Year Trading Update 2021 & Notice of Results
08 Jan 2021 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
05 Jan 2021 7:00 am
RNS
Initiation of peanut allergy biomarker study
14 Dec 2020 3:58 pm
RNS
Director/PDMR Shareholding
08 Dec 2020 2:42 pm
RNS
Result of Annual General Meeting
20 Nov 2020 1:51 pm
RNS
Grant of Awards under Long Term Incentive Plan
  7:00 am
RNS
Director/PDMR Shareholding
10 Nov 2020 7:05 am
RNS
Annual Report & Accounts and AGM Notification
26 Oct 2020 7:00 am
RNS
Initiation of Grass MATA MPL exploratory study

a d v e r t i s e m e n t